The Purdue Pharma Bankruptcy Case: What’s at Stake

Purdue Pharma has been accused of fueling the opioid epidemic with overly aggressive marketing practices for its OxyContin brand. What would a proposed settlement mean for the company and for opioid victims? Hosted on Acast. See for more information.

by Knowledge at Wharton